Dr Reddy's Laboratories Ltd has announced that the US Food and Drug Administration has granted final approval for the company's Abbreviated New Drug Application (ANDA) for fexofenadine hydrochloride ...
ALLEGAN, Mich., April 13, 2011 /PRNewswire/ -- Perrigo (Nasdaq: PRGO;TASE) today announced that its partner, Teva Pharmaceutical Industries, Ltd. (Nasdaq: TEVA), has received final OTC approval to ...
Hyderabad-based Dr. Reddy's Laboratories today said that it had entered the $452 million Fexofenadine market with the launch of its over-the-counter fexofenadine hydrochloride tablets. The ...
Dr Reddy’s Laboratories has launched its over-the-counter (OTC) fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg, a bioequivalent generic version of ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New ...
Hay fever sufferers are praising a type of over-the-counter hay fever relief that used to only be available on prescription on the NHS. Fexofenadine Hydrochloride tablets were previously only ...